Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747589 · ClinicalTrials.gov registry record · NA
Feasibility of Stimulating the Visual Cortex in Blind
A NA study of Blindness,Acquired, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT02747589 is a NA study of Blindness,Acquired that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02747589, a NA study of Blindness,Acquired, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators intend to evaluate the use of a commercially available neurostimulator system, NeuroPace RNS System to stimulate the visual cortex. The NeuroPace RNS System has a proven record of safety and reliability was approved by the FDA in November 2013. The RNS System is indicated for use in patients with epilepsy and includes a skull implanted neurostimulator. No modification to the RNS System is required for this study. This study will use this device to better understand the effect of stimulation on the visual parts of the brain. The main purposes of this study are to confirm the desired location to implant a device in the visual cortex, determine the amount of energy needed to elicit vision, and assess the nature of the vision that is produced. This information is important to have early in the process of designing a visual cortical prosthesis that could eventually be used for commercial use.
Conditions Studied
Interventions
- PROCEDURE Surgical device implant in brain
Study Locations (1)
California
- UCLA Department of Neurosurgery - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-08 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747589
The ClinicalTrials.gov registry entry for NCT02747589 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blindness,Acquired appearing as the primary indexed condition, and to 1 intervention - of which Surgical device implant in brain is the first listed.
NCT02747589 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02747589 about?
NCT02747589 is a clinical study titled "Feasibility of Stimulating the Visual Cortex in Blind". In this study, the investigators intend to evaluate the use of a commercially available neurostimulator system, NeuroPace RNS System to stimulate the visual cortex. The NeuroPace RNS System has a proven record of safety and reliability was approved by the FDA in November 2013. The RNS System is indi...
What is the current status of trial NCT02747589?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2016-08. Estimated completion is 2026-12-31.
What conditions does trial NCT02747589 study?
This clinical trial studies the following conditions: Blindness,Acquired.
What interventions are being tested in trial NCT02747589?
The interventions under investigation include: Surgical device implant in brain (PROCEDURE).
Who is sponsoring clinical trial NCT02747589?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747589 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.